Production (Stage)
Instil Bio, Inc.
TIL
$35.30
$2.417.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -14.17% | -9.00% | -15.22% | -20.15% | -25.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.26% | -33.78% | -45.12% | -52.40% | -58.91% |
| Operating Income | 28.26% | 33.78% | 45.12% | 52.40% | 58.91% |
| Income Before Tax | 36.72% | 52.50% | 61.96% | 35.98% | 45.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.72% | 52.50% | 61.85% | 35.64% | 45.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.72% | 52.50% | 61.85% | 35.64% | 45.46% |
| EBIT | 28.26% | 33.78% | 45.12% | 52.40% | 58.91% |
| EBITDA | 28.63% | 34.31% | 45.80% | 52.92% | 59.56% |
| EPS Basic | 36.86% | 52.53% | 61.86% | 35.73% | 45.60% |
| Normalized Basic EPS | 29.92% | 30.83% | 41.97% | 49.18% | 59.13% |
| EPS Diluted | 36.86% | 52.53% | 61.87% | 35.73% | 45.60% |
| Normalized Diluted EPS | 29.92% | 30.83% | 41.97% | 49.18% | 59.13% |
| Average Basic Shares Outstanding | 0.20% | 0.09% | 0.04% | 0.12% | 0.25% |
| Average Diluted Shares Outstanding | 0.20% | 0.09% | 0.04% | 0.12% | 0.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |